title: New paradigms in PCOS: impaired glucose tolerance and cardiovascular risk. Clinical approach.
abstract: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder amongst women of reproductive age and is associated with various metabolic risk factors, in addition to chronic anovulation and factors related to androgen excess. Women with PCOS have a higher risk of insulin resistance, hyperinsulinemia, glucose intolerance, dyslipidemia, and an increased prothrombotic state, resulting in a higher risk of type 2 diabetes mellitus, subclinical atherosclerosis, vascular dysfunction, and apparently cardiovascular disease and mortality. The aim of the present article was to summarize current knowledge with focus on a suggestion to the clinical approach and handling of these metabolic risk factors.
authors: Department of Gynecology and Obstetrics Odense University Hospital, Odense, Denmark - pernille.ravn@rsyd.dk.
authors: P
authors: P
authors: Ravn
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology*; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000209:etiology; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008659:Metabolic Diseases / Q000453:epidemiology / Q000209:etiology*; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000453:epidemiology; D012307:Risk Factors